Prenatal Diagnostics Co. Natera Sets Terms For $100M IPO

By Chelsea Naso (June 22, 2015, 1:36 PM EDT) -- Venture capital-backed Natera Inc., which markets a suite of prenatal tests, set terms for a $100 million initial public offering on Monday, banking on investor appetite for the diagnostics company as it looks to apply its technology to the oncology space....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!